Lysophosphatidic acid (LPA)‐induced vasodilator‐stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC‐3 prostate cancer cells

Prostate cancer remains the most frequently diagnosed malignancy and the second leading cause of cancer mortality among men in the United States. Hormone refractory, metastatic disease has no molecular therapeutics to date and survival is poor. Lysophosphatidic acid (LPA) is a bioactive lipid exhibi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hasegawa, Yutaka, Murph, Mandi, Yu, Shuangxing, Tigyi, Gabor, Mills, Gordon B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2008
Konular:
Papers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2597858/
https://ncbi.nlm.nih.gov/pubmed/19081821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2008.03.009
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller